Amicus Therapeutics Inc (FOLD) Insider Trading

Total insider buys:
  • $71,123,425.77
Total insider sells:
  • $145,122,652.45
Most recent insider trade:
  • Nov. 6, 2024
Most active insider trader:
  • John F Crowley
Trader NameDateTitleAmountPriceTypeTotal Value
Dec. 16, 2019CEO20,000$9.55Sell$191,000.00
Dec. 2, 2019CEO20,000$10.38Sell$207,600.00
Nov. 25, 2019CEO40,000$10.01Sell$400,400.00
Nov. 15, 2019CEO20,000$9.52Sell$190,400.00
Nov. 8, 2019CEO20,000$9.02Sell$180,400.00
Oct. 11, 2019CEO14,500$8.01Sell$116,145.00
Sept. 11, 2019CEO20,000$10.05Sell$201,000.00
Aug. 23, 2019Director4,945$10.07Buy$49,796.15
Aug. 1, 2019CEO20,000$12.54Sell$250,800.00
July 1, 2019CEO20,000$12.47Sell$249,400.00
June 3, 2019Director5,000$11.16Sell$55,800.00
June 3, 2019CEO20,000$11.15Sell$223,000.00
May 1, 2019CEO20,000$13.51Sell$270,200.00
April 5, 2019Insider50,000$14.20Sell$710,000.00
April 1, 2019CEO20,000$13.63Sell$272,600.00
March 1, 2019CEO20,000$13.60Sell$272,000.00
Feb. 25, 2019Insider70,000$12.52Sell$876,400.00
Feb. 1, 2019CEO20,000$12.12Sell$242,400.00
Jan. 22, 2019COO36,000$11.81Sell$425,160.00
Jan. 16, 2019Insider53,269$12.03Sell$640,826.07
Jan. 15, 2019CEO103,500$11.71Sell$1,211,985.00
Oct. 15, 2018CFO10,000$12.23Sell$122,300.00
Oct. 3, 2018Major Shareholder50,000$12.59Buy$629,500.00
Sept. 24, 2018Major Shareholder20,000$12.45Buy$249,000.00
Sept. 21, 2018Major Shareholder50,000$12.53Buy$626,500.00
Sept. 12, 2018Major Shareholder500,000$12.00Buy$6,000,000.00
July 2, 2018SVP5,000$15.63Sell$78,150.00
July 2, 2018CFO10,000$15.63Sell$156,300.00
June 1, 2018Insider25,000$16.72Sell$418,000.00
May 16, 2018Insider25,000$15.00Sell$375,000.00
May 16, 2018Director10,000$16.00Sell$160,000.00
May 14, 2018Insider5,000$14.04Sell$70,200.00
April 17, 2018Insider50,000$15.00Sell$750,000.00
April 16, 2018Director5,000$14.41Sell$72,050.00
April 12, 2018Insider5,000$14.72Sell$73,600.00
April 2, 2018SVP5,000$14.27Sell$71,350.00
April 2, 2018CFO10,000$14.26Sell$142,600.00
March 12, 2018Insider5,000$15.05Sell$75,250.00
March 9, 2018SVP8,750$15.00Sell$131,250.00
March 5, 2018Major Shareholder335,827$13.56Buy$4,553,814.12
March 1, 2018SVP8,149$14.06Sell$114,574.94
March 1, 2018Major Shareholder100,000$13.69Buy$1,369,000.00
Jan. 23, 2018Insider20,000$16.80Sell$336,000.00
Jan. 22, 2018COO32,500$15.92Sell$517,400.00
Jan. 2, 2018Insider5,000$14.71Sell$73,550.00
Jan. 2, 2018SVP8,000$14.72Sell$117,760.00
Jan. 2, 2018Director20,000$15.00Sell$300,000.00
Jan. 2, 2018CFO10,000$14.72Sell$147,200.00
Dec. 29, 2017CEO18,970$14.75Sell$279,807.50
Dec. 29, 2017CEO5,920$14.75Sell$87,320.00
  • Insiders are both buying and selling Amicus Therapeutics Inc stock.

  • The insider traders at Amicus Therapeutics Inc are: John F Crowley, Bradley L Campbell, Jay Barth, Hung Do, Burke W Whitman, Daphne Quimi, William D Baird III, Perceptive Advisors Llc, Ellen Rosenberg, Jeff Castelli, Samantha Prout, Margaret G Mcglynn, Michael Raab, David Michael Clark, Life Sciences Maste Perceptive, Kenneth Peist, Jayne Gershkowitz, Glenn Sblendorio, Julie Yu, Donald J Hayden Jr, Kurt J Andrews, Plc Glaxosmithkline, Ken Valenzano, Bradley L. Campbell, Enrique Dilone, William D. Baird III, Burke W. Whitman, Dipal Doshi, Joan Winterbottom, John F. Crowley, Lynn Dorsey Bleil, and Sol J Barer

  • The most active insider trader at Amicus Therapeutics Inc is John F Crowley with 110 trades.

  • Plc Glaxosmithkline has sold the most Amicus Therapeutics Inc stock with a total value of $119,721,428.50.

  • Perceptive Advisors Llc has bought the most Amicus Therapeutics Inc stock with a total value of $40,474,740.62.

  • The most recent insider trade for Amicus Therapeutics Inc was on Nov. 6, 2024.

  • The single biggest insider buy for Amicus Therapeutics Inc was from Life Sciences Maste Perceptive with a total value of $18,375,000.00 on July 13, 2017.

  • The single biggest insider sell for Amicus Therapeutics Inc was from Plc Glaxosmithkline with a total value of $59,860,714.25 on Oct. 27, 2014.